David Nichols & Franz Vollenweider Q&A: Psychedelic Neuroscience

preview_player
Показать описание

David Nichols, PhD, and Franz Vollenweider, MD
Q&A: Psychedelic Neuroscience

Psychedelic Science 2017
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.
Рекомендации по теме